SC

Sudarshan Chemical Industries Ltd

Q1 FY27Chemicals & Petrochemicals

Sudarshan Chemical Industries Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹1,248
Market cap₹9.7K Cr
P/E95.9
Updated13 Sept 2026
Read4 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

Post Heubach acquisition, Sudarshan aims for measured revenue growth, focusing on capturing lost sales rather than aggressive expansion. Sudarshan Chemical aims for significant growth, targeting a turnover of over Rs.12,000 Crores plus in the medium term (Slide 9 referenced).

From Sudarshan Chemical Industries Ltd's Q1 FY27 earnings-call transcript · updated 13 Sept 2026.

Revenue & Sales Performance

Moderate growth
  • Post Heubach acquisition, Sudarshan aims for measured revenue growth, focusing on capturing lost sales rather than aggressive expansion.
  • Current market share limits growth beyond overall market size, but there is substantial opportunity in regaining lost business.
  • Target to exceed Rs.12,000 Crores in topline, combining legacy and acquired businesses.
  • Legacy Sudarshan business expected to grow at 12-13%.
  • Focus on profitable growth, maintaining/growing gross margins with premium products.
  • Revenue CAGR of 5-7% over next 2-3 years anticipated, comprising both volume and value growth.
  • Confidence to grow at 2 to 2.5 times the industry growth rate due to lost business recovery and value capture initiatives.

2 more points from Sudarshan Chemical Industries Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Sudarshan Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • No substantial new capex is expected in the near term as current capacities are sufficient for projected growth.
  • Moderate capex may be undertaken for special initiatives such as backward integration or product development projects, based strictly on ROI.
  • The company is progressing with Project Integra (One SAP) to integrate and harmonize reporting systems, expected to go live within the financial year.

2 more points from Sudarshan Chemical Industries Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 2
2Solar Industries
Rev 2Mar 1
3
Rev 2Mar 1
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sudarshan Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention current or expected order book or pending orders for Sudarshan Chemical Industries Limited. However, relevant insights include: - The company is confident about recovering and growing lost business from the acquired group, which suffered due to lack of focus and insolvency issues. - Supply chain continuity is maintained through sufficient safety stocks and logistics adjustments amid geopolitical uncertainties.

2 more points from Sudarshan Chemical Industries Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Sudarshan Chemical Industries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.8K Cr, net profit ₹82 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Lords Chloro Alkali Ltd (Q1 FY27)

    106.34 crore, a 6.88% YoY increase from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q1 FY27 investor presentation — and how it ranks

  • Prasol Chemicals Ltd (Q1 FY27)

    Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank

  • Fine Organic Industries Ltd (Q1 FY27)

    Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

  • Chemfab Alka. (Q1 FY27)

    Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key concall takeaways from Chemfab Alkalis Ltd's Q1…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sudarshan Chemical Industries Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sudarshan Chemical Industries Ltd Q1 FY27 results?

Post Heubach acquisition, Sudarshan aims for measured revenue growth, focusing on capturing lost sales rather than aggressive expansion. Sudarshan Chemical aims for significant growth, targeting a turnover of over Rs.12,000 Crores plus in the medium term (Slide 9 referenced).

What is Sudarshan Chemical Industries Ltd share price analysis?

Sudarshan Chemical Industries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 95.9 with a market cap of ₹9,735 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sudarshan Chemical Industries Ltd planning capital expenditure?

No substantial new capex is expected in the near term as current capacities are sufficient for projected growth.

Keep Sudarshan Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.